Diabetic dyslipidemia

被引：181
作者：
Chahil, Tina J. [1 ]
Ginsberg, Henry N. [1 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2006年 / 35卷 / 03期
关键词：
D O I：
10.1016/j.ecl.2006.06.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes mellitus is associated with a markedly increased risk of cardiovascular disease. A complex dyslipidemia, which is an integral part of the underlying insulin resistance in this group, is a key to this increased risk. Increased secretion of VLDL from the liver is a central feature of dyslipidemia and is linked significantly to the low HDL and abnormal LDL that are also present. A number of physiologic and pharmacologic approaches are available and should be used aggressively to treat diabetic dyslipidemia.
引用
收藏
页码：491 / +
页数：22
相关论文
共 76 条
  • [1] Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
    Altomonte, J
    Cong, L
    Harbaran, S
    Richter, A
    Xu, J
    Meseck, M
    Dong, HJH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (10) : 1493 - 1503
  • [2] [Anonymous], 2005, National diabetes fact sheet
  • [3] LDL DENSITY AND ATHEROSCLEROSIS
    AUSTIN, MA
    KRAUSS, RM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (02): : 115 - 115
  • [4] Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease - 10-year follow-up of the Hoorn Study
    Becker, A
    Bos, G
    de Vegt, F
    Kostense, PJ
    Dekker, JM
    Nijpels, G
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (15) : 1406 - 1413
  • [5] Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
    Beckman, JA
    Creager, MA
    Libby, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19): : 2570 - 2581
  • [6] Bjorkegren J, 1996, J LIPID RES, V37, P76
  • [7] Increased ApoB in small dense LDL particles predicts premature coronary artery disease
    Brunzell, JD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) : 474 - 475
  • [8] EVIDENCE FOR A COMMON, SATURABLE, TRIGLYCERIDE REMOVAL MECHANISM FOR CHYLOMICRONS AND VERY LOW-DENSITY LIPOPROTEINS IN MAN
    BRUNZELL, JD
    HAZZARD, WR
    PORTE, D
    BIERMAN, EL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) : 1578 - 1585
  • [9] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN
    CANNER, PL
    BERGE, KG
    WENGER, NK
    STAMLER, J
    FRIEDMAN, L
    PRINEAS, RJ
    FRIEDEWALD, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1245 - 1255
  • [10] Critical review of acylation-stimulating protein physiology in humans and rodents
    Cianflone, K
    Xia, ZN
    Chen, LY
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (02): : 127 - 143
12345678